NDC 55150-394 – Fulvestrant
Fulvestrant 50 mg/mL · Injection · Intravenous
Product NDC55150-394
Product details
- Brand name
- Fulvestrant
- Generic name
- Fulvestrant
- Labeler
- Eugia US LLC
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA215169
- Marketed since
- June 30, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Estrogen Receptor Antagonist
Active ingredients
- Fulvestrant 50 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55150-394-02 | 2 SYRINGE in 1 CARTON (55150-394-02) / 5 mL in 1 SYRINGE | Jun 30, 2023 |
Other Fulvestrant products
- 16729-436 Fulvestrant 250 mg/5mL · Injection · Accord Healthcare Inc.
- 62332-650 Fulvestrant 50 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 70121-1463 Fulvestrant 250 mg/5mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 70860-211 Fulvestrant 50 mg/mL · Injection, Solution · Athenex Pharmaceutical Division, LLC.
- 83634-203 Fulvestrant 50 mg/mL · Injection, Solution · Avenacy, Inc.
- 68001-522 Fulvestrant 250 mg/5mL · Injection · BluePoint Laboratories
- 68001-484 Fulvestrant 250 mg/5mL · Injection, Solution · BluePoint Laboratories
- 68001-626 Fulvestrant 50 mg/mL · Injection · BluePoint Laboratories.
- 71731-6121 Fulvestrant 50 mg/mL · Injection · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- 43598-262 Fulvestrant 50 mg/mL · Injection, Solution · Dr.Reddy's Laboratories Inc
- 63323-715 Fulvestrant 50 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 68462-317 Fulvestrant 50 mg/mL · Injection · GLENMARK PHARMACEUTICALS INC., USA